Skip to main content
. Author manuscript; available in PMC: 2016 Dec 17.
Published in final edited form as: Brain Inj. 2015 Jun 17;29(10):1165–1174. doi: 10.3109/02699052.2015.1035330

Figure 5.

Figure 5

The effect of a combination of progesterone and VDH on the expression of GFAP and MAP-2 at 24 h after TBI. A. Representative bands of GFAP shown by western blot. B. Adjusted density of GFAP. C. Representative bands of MAP-2 shown by western blot. D. Adjusted density of MAP-2. n=5, α: p < 0.05 vs.Sham; β: p < 0.05 vs. with TBI; γ: p < 0.05 vs. with TBI+P and TBI+D. Sham: sham with vehicle treatment group; TBI: TBI with vehicle treatment group; TBI+P: TBI with progesterone treatment group; TBI+D: TBI with vitamin D treatment group; TBI+P+D: TBI with progesterone and vitamin D combination treatment group, n=5.